209 related articles for article (PubMed ID: 37728342)
1. A novel
Odongo L; Habtegebrael BH; Kiessling V; White JM; Tamm LK
Microbiol Spectr; 2023 Sep; 11(5):e0190823. PubMed ID: 37728342
[TBL] [Abstract][Full Text] [Related]
2. Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step.
Mingo RM; Simmons JA; Shoemaker CJ; Nelson EA; Schornberg KL; D'Souza RS; Casanova JE; White JM
J Virol; 2015 Mar; 89(5):2931-43. PubMed ID: 25552710
[TBL] [Abstract][Full Text] [Related]
3. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
[TBL] [Abstract][Full Text] [Related]
4. Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway.
Spence JS; Krause TB; Mittler E; Jangra RK; Chandran K
mBio; 2016 Feb; 7(1):e01857-15. PubMed ID: 26861015
[TBL] [Abstract][Full Text] [Related]
5. Induction of Cell-Cell Fusion by Ebola Virus Glycoprotein: Low pH Is Not a Trigger.
Markosyan RM; Miao C; Zheng YM; Melikyan GB; Liu SL; Cohen FS
PLoS Pathog; 2016 Jan; 12(1):e1005373. PubMed ID: 26730950
[TBL] [Abstract][Full Text] [Related]
6. A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its Inhibition.
Bortz RH; Wong AC; Grodus MG; Recht HS; Pulanco MC; Lasso G; Anthony SJ; Mittler E; Jangra RK; Chandran K
J Virol; 2020 Aug; 94(18):. PubMed ID: 32611759
[TBL] [Abstract][Full Text] [Related]
7. Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by
Mittler E; Alkutkar T; Jangra RK; Chandran K
mBio; 2021 Jan; 12(1):. PubMed ID: 33436438
[TBL] [Abstract][Full Text] [Related]
8. Filoviruses Use the HOPS Complex and UVRAG To Traffic to Niemann-Pick C1 Compartments during Viral Entry.
Bo Y; Qiu S; Mulloy RP; Côté M
J Virol; 2020 Jul; 94(16):. PubMed ID: 32493822
[TBL] [Abstract][Full Text] [Related]
9. Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments.
Stewart CM; Phan A; Bo Y; LeBlond ND; Smith TKT; Laroche G; Giguère PM; Fullerton MD; Pelchat M; Kobasa D; Côté M
PLoS Pathog; 2021 Jan; 17(1):e1009275. PubMed ID: 33513206
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change.
Brecher M; Schornberg KL; Delos SE; Fusco ML; Saphire EO; White JM
J Virol; 2012 Jan; 86(1):364-72. PubMed ID: 22031933
[TBL] [Abstract][Full Text] [Related]
11. Lamp1 Increases the Efficiency of Lassa Virus Infection by Promoting Fusion in Less Acidic Endosomal Compartments.
Hulseberg CE; Fénéant L; Szymańska KM; White JM
mBio; 2018 Jan; 9(1):. PubMed ID: 29295909
[TBL] [Abstract][Full Text] [Related]
12. MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation.
Yu C; Li S; Zhang X; Khan I; Ahmad I; Zhou Y; Li S; Shi J; Wang Y; Zheng YH
mBio; 2020 Sep; 11(5):. PubMed ID: 32934085
[TBL] [Abstract][Full Text] [Related]
13. An exploration of conditions proposed to trigger the Ebola virus glycoprotein for fusion.
Fénéant L; Szymańska-de Wijs KM; Nelson EA; White JM
PLoS One; 2019; 14(7):e0219312. PubMed ID: 31276481
[TBL] [Abstract][Full Text] [Related]
14. Acidic pH Triggers Lipid Mixing Mediated by Lassa Virus GP.
Bulow U; Govindan R; Munro JB
Viruses; 2020 Jul; 12(7):. PubMed ID: 32630688
[TBL] [Abstract][Full Text] [Related]
15. A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry.
Fels JM; Spence JS; Bortz RH; Bornholdt ZA; Chandran K
mBio; 2019 Jul; 10(4):. PubMed ID: 31289183
[TBL] [Abstract][Full Text] [Related]
16. Filovirus entry: a novelty in the viral fusion world.
Hunt CL; Lennemann NJ; Maury W
Viruses; 2012 Feb; 4(2):258-75. PubMed ID: 22470835
[TBL] [Abstract][Full Text] [Related]
17. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1.
Carette JE; Raaben M; Wong AC; Herbert AS; Obernosterer G; Mulherkar N; Kuehne AI; Kranzusch PJ; Griffin AM; Ruthel G; Dal Cin P; Dye JM; Whelan SP; Chandran K; Brummelkamp TR
Nature; 2011 Aug; 477(7364):340-3. PubMed ID: 21866103
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins.
Plegge T; Spiegel M; Krüger N; Nehlmeier I; Winkler M; González Hernández M; Pöhlmann S
PLoS One; 2019; 14(4):e0214968. PubMed ID: 30973897
[TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection.
Côté M; Misasi J; Ren T; Bruchez A; Lee K; Filone CM; Hensley L; Li Q; Ory D; Chandran K; Cunningham J
Nature; 2011 Aug; 477(7364):344-8. PubMed ID: 21866101
[TBL] [Abstract][Full Text] [Related]
20. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies.
Bornholdt ZA; Ndungo E; Fusco ML; Bale S; Flyak AI; Crowe JE; Chandran K; Saphire EO
mBio; 2016 Feb; 7(1):e02154-15. PubMed ID: 26908579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
